Skip to main content
. Author manuscript; available in PMC: 2023 Oct 10.
Published in final edited form as: Cancer Cell. 2022 Sep 29;40(10):1161–1172.e5. doi: 10.1016/j.ccell.2022.08.022

Figure 5: See also Table S6. Ancestry-specific associations between TMB status and overall survival (OS) among ICI-treated patients with NSCLC.

Figure 5:

A. Association between TMB and OS in European ancestry in the DFCI cohort. B. Association between TMB and OS in Asian ancestry in the DFCI cohort. C. Association between TMB and OS in African ancestry in the DFCI cohort. D. Association between TMB and OS in European ancestry in the MSKCC cohort. E. Association between TMB and OS in Asian ancestry in the MSKCC cohort. F. Association between TMB and OS in African ancestry in the MSKCC cohort. For the DFCI and MSKCC cohorts, calibrated TMB and tumor/normal TMB were analyzed, respectively. P-values were adjusted for prior lines of therapy, ICI type, TMB-c, treatment prior to sequencing and histologic subtype. See also Table S6.